Skip to content

PHARMEDIC

Active Private limited companyfounded 2018active for 7 yearsRue du Fays 1, 5336 AssesseKBO/BCE: BE 0715.682.133 #6 company by total assets in Assesse, Manufacturing sector
PHARMEDIC
Financial year 2025
Follow ReportCompare

Annual accounts 2025

micro format, filed on 26-08-2026, 26 days late
€223,924
▲ 37.9%
€109,203
▲ 91.1%
€54,336
▲ 189%
€5,100
▲ €26,373
10.1%
▲ 4.2 percentage points
1.01
▲ 0.08

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €560,000. Estimated: probably between €370,000 and €870,000.

In the rankings #6 company by total assets in Assesse, Manufacturing sector

Balance sheet

balance sheet total €1.3m on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

10.1%

Higher than 16% of 2,343 companies in 2025.

1.01

Higher than 27% of 2,309 companies in 2025.

4.2%

Higher than 43% of 2,323 companies in 2025.

PHARMEDIC Middle half of the sector 80% of the sector Micro accounts in fabricated metal products (NACE 25)

Net result: top quarter · Equity: middle half · Balance sheet total: top quarter · Working capital: middle half

Staff

€37,788

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019
Balance sheet: assets
20/58 1.3m1.3m1.3m183,165151,059146,933207,721
21/28 927,829969,253976,04423,79346,73573,56194,964
21 143,500162,661182,4191,4963,3545,6998,044
22/27 784,329806,591793,62522,29743,38167,86286,920
22 709,016702,345721,213----
23 34,13745,0406,91011,75423,54538,66553,788
24 41,17659,20765,50210,54319,83529,19733,132
29/58 356,868319,702318,961159,371104,32573,373112,757
3 210,245163,384145,98368,40035,000-30,000
30/36 210,245163,384109,183----
37 --36,80068,40035,000-30,000
40/41 87,24254,16750,53984,50959,90757,31066,923
40 62,27935,64646,01384,21359,61132,02229,432
41 24,96318,5214,52629629625,28837,491
54/58 57,121100,486117,4863,3068,50215,03514,674
490/1 2,2611,6664,9533,1569161,0281,160
Balance sheet: equity and liabilities
10/49 1.3m1.3m1.3m183,165151,059146,933207,721
10/15 129,92175,58556,80855,21444,92940,48832,971
10/11 18,60018,60018,60018,60018,60018,60018,600
100 ------18,600
13 81,25626,9208,2208,2208,2208,220720
130/1 720720720720720720-
130 ------720
1311 720720720720720720-
133 80,53626,2007,5007,5007,5007,500-
14 30,06530,06529,98828,39418,10913,66813,651
17/49 1.2m1.2m1.2m127,950106,131106,445174,750
17 803,008872,395907,2321,84823,86345,59367,042
170/4 803,008872,395907,2321,84823,86345,59367,042
42/48 351,768340,975330,964126,10282,26860,703107,708
42 70,42974,43658,93622,01521,73021,44921,171
43 6,7326,757----6,692
430/8 6,7326,757----6,692
44 47,53620,55750,57865,21032,86033,23734,233
440/4 47,53620,55750,57865,21032,86033,23734,233
45 9,1094,7617,5227,01722,9175,7405,621
450/3 3,6822,006629-11,109750-
454/9 5,4272,7546,8947,01711,8094,9905,621
47/48 217,962234,465213,92731,8614,76127739,990
492/3 -----149-
Income statement
9900 223,924162,418179,884115,994104,324100,489118,903
62 34,00929,16373,42281,55071,37863,61877,931
630 78,97874,20885,76722,94126,82626,45022,720
640/8 1,7331,9047681643096531,205
9901 109,20357,14419,92811,3395,8119,76917,047
75/76B 81-581-11112
75 81-581-11112
65/66B 41,78136,49718,9151,0531,3721,6122,678
65 41,78136,49718,9151,0531,3721,6122,678
9903 67,50320,6471,59410,2864,4418,26814,371
67/77 13,1671,870---750-
9904 54,33618,7771,59410,2864,4417,51814,371
9905 54,33618,7771,59410,2864,4417,51814,371
Appropriation of the result
9906 84,40148,76529,98828,39418,10921,16814,371
14P 30,06529,98828,39418,10913,668--
691/2 54,33618,700---7,500720
6920 ------720
6921 54,33618,700---7,500-
Social balance sheet
9087 0.90.523.12.92.12
Hours worked1013 1,1449552,6513,3523,1522,6833,528
Document PDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 13 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 26-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 26 days after the deadline. Filed on 26 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00447245.

Financial year Type Filed Reference Document
31-12-2025 micro format 26-08-2026 2026-00447245 PDF
31-12-2024 micro format 29-09-2025 2025-00523051 PDF
31-12-2023 micro format 30-09-2024 2024-00489734 PDF
31-12-2022 micro format 31-08-2023 2023-00427229 PDF
31-12-2021 micro format 31-08-2022 2022-20409484 PDF
31-12-2020 micro format 30-08-2021 2021-57700307 PDF
31-12-2019 micro format 31-08-2020 2020-47800527 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019
188,181131,352105,69434,28032,63736,21839,767
133,31592,98587,36033,22731,26733,96737,091
37,55467,4171.0m005,046117,685
-43,365-17,001114,180-5,196-6,534361-
5,100-21,273-12,00333,26922,05712,6695,049
10.1%5.9%4.4%30.1%29.7%27.6%15.9%
1.010.940.961.261.271.211.05
0.420.460.520.720.841.210.77
8.8916.0521.802.322.362.635.30
41.8%24.8%2.8%18.6%9.9%18.6%43.6%
4.2%1.5%0.1%5.6%2.9%5.1%6.9%
4.503.605.5932.5623.79--

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-202331-12-202231-12-2021
Employees at the balance-sheet date11133
full-time--133
part-time11---
in full-time equivalents0.80.5133
0.70.523.12.9
On a permanent contract11133
Joined-10--
Left-12--

Source: social balance sheet in the 2021 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item20252024202320222021
Mortgages, amount registered€27,500€27,500€27,500--
€665,000€665,000€665,000--
Carrying value of the mortgaged assets€610,928€629,828€648,728--
€170,000€170,000€170,000€120,000€120,000

Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€37,554€67,417€846,403--
Intangible fixed assets--€191,614--
€78,978€74,208€85,767€22,941€26,826

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMEDIC

The operating result for 2025 is 91% higher than in 2024 and the highest since 2019. It is the fourth rise in a row, after the fall in 2021.

Debt's share of the balance-sheet total falls from 94.1% to 89.9%. Equity is higher and debt is lower.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure